Cargando…
Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report
Tardive dyskinesia (TD) is a common side effect of antipsychotics, and it remains a persistent and challenging problem. The blonanserin transdermal patch, developed in Japan and launched in September 2019, is the first antipsychotic transdermal treatment. Here, we describe a patient with schizophren...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411311/ https://www.ncbi.nlm.nih.gov/pubmed/34357702 http://dx.doi.org/10.1002/npr2.12200 |